What:
A prognostic and predictive glycomic marker for Inflammatory Bowel disease (IBD)

Applications:
Prognosis and prediction of need for treatment escalation for newly diagnosed IBD patients. Complementary diagnostic for IBD drugs

Clients:
IBD clinicians, biopharma companies performing clinical trials for IBD

Development Stage:
TRL 6, Designing further clinical studies

What:
Multi-dimensional glycomic marker to  measure Chronic inflammation (CI) and Immunofrailty

Applications:
Early detection of CIDs, susceptibility to aIDs, personalization of anti-inflammatory protocols

Clients:
Precision health and wellness companies, regenerative medicine, health-conscious individual clients

Development Stage:
TRL 8, Can be ordered commercially

What:
Glycomic biomarker to identify immunofrail individuals who would be (a) vulnerable to inflammatory storms from COVID-19 and (b) potential non-responders to SARS-Cov-2 vaccines.

Applications:
Selection of patients to clinical trials of SARS-Cov-2 vaccines.

Clients:
Vaccine developers

Development stage:
TRL 5, feasibility study successfully completed. Designing proof of concept.

What:
A prognostic and predictive glycomic marker for Inflammatory Bowel disease (IBD)

What:
Multi-dimensional glycomic marker to  measure Chronic inflammation (CI) and Immunofrailty

What:
Glycomic biomarker to identify immunofrail individuals who would be (a) vulnerable to inflammatory storms from COVID-19 and (b) potential non-responders to SARS-Cov-2 vaccines.

Applications:
Prognosis and prediction of need for treatment escalation for newly diagnosed IBD patients. Complementary diagnostic for IBD drugs

Applications:
Early detection of CIDs, susceptibility to aIDs, personalization of anti-inflammatory protocols

Applications:
Selection of patients to clinical trials of SARS-Cov-2 vaccines.

Clients:
IBD clinicians, biopharma companies performing clinical trials for IBD

Clients:
Precision health and wellness companies, regenerative medicine, health-conscious individual clients

Clients:
Vaccine developers

Development Stage:
TRL 6, Designing further clinical studies

Development Stage:
TRL 8, Can be ordered commercially

Development stage:
TRL 5, feasibility study successfully completed. Designing proof of concept.